June 20 - 21 2024

Dear Friends:

On behalf of the Colorectal Cancer Resource & Action Network (CCRAN), welcome to the second annual, pan-tumor Biomarkers Conference focusing on timely and equitable access to biomarker testing results and comprehensive genomic profiling (CGP) for all metastatic cancer patients in Canada.

We are thrilled to once again be collaborating with multiple cancer patient advocacy groups, as we come together collectively to address the challenges and barriers in respect of biomarker testing and CGP to improve patient outcomes, challenge healthcare inequities, and drive value in the healthcare system in Canada.

This year’s Conference builds on the objectives and outcomes of the inaugural 2023 event. Working closely with other patient advocacy groups across Canada, our conference will convene clinical, policy, research, and patient experts to examine:

• Challenges, barriers and opportunities in biomarker testing and comprehensive genomic profiling
• Implementation and policy considerations to move the needle forward for comprehensive genomic profiling as a future standard of cancer care in Canada
• The business case for optimizing access to precision medicines and the role of real-world evidence in decision-making
• The utility of ctDNA in clinical practice in the adjuvant and metastatic disease settings
• Patients’ lived experience and reported outcomes regarding access to biomarker testing results and comprehensive genomic profiling across cancer types.

Precision medicine is transforming cancer care and providing significant benefits to people living with different types of cancer. But it can only achieve these benefits through wide and timely access to advanced biomarker testing or comprehensive genomic profiling. Join us for engaging and thought-provoking discussion with experts across Canada and internationally.

CCRAN will happily serve as a resource on each of these topics post conference; hence, we welcome inquiries and outreach. We look forward to your online engagement on June 20th and 21st. Please do not hesitate to reach out to us with any questions or concerns regarding our conference to Cassandra Macaulay at Cassandra.m@ccran.org.

Warmly,

Filomena Servidio-Italiano

President & CEO, CCRAN

With immense gratitude, we extend our thanks to the following patient advocacy groups for their collaboration on CCRAN’s 2024 Pan-Tumour Patient Survey, and for their participation in the Biomarkers Conference: